Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Sep;44(9):3381-3.
doi: 10.1128/JCM.00751-06.

Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs

G N Forrest  1 , K Mankes, M A Jabra-Rizk, E Weekes, J K Johnson, D P Lincalis, R A Venezia
Affiliations

Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs

G N Forrest et al. J Clin Microbiol. 2006 Sep.

Abstract

The impact of rapid identification of Candida albicans blood isolates by peptide nucleic acid fluorescence in situ hybridization (PNA FISH) on the selection and expenditure of antifungal therapy was evaluated. PNA FISH was 100% sensitive and specific in the rapid identification of 31 out of 72 candidemias as C. albicans and resulted in a significant reduction of caspofungin usage, with an overall cost savings of 1,729 US dollars per patient.

PubMed Disclaimer

References

    1. Alexander, B. D., E. D. Ashley, L. B. Reller, and S. D. Reed. 2006. Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn. Microbiol. Infect. Dis. 54:277-282. - PubMed
    1. Cuenca-Estrella, M., W. Lee-Yang, M. A. Ciblak, B. A. Arthington-Skaggs, E. Mellado, D. W. Warnock, and J. L. Rodriguez-Tudela. Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species. Antimicrob. Agents Chemother. 46:3644-3647. - PMC - PubMed
    1. Jabra-Rizk, M. A., J. K. Johnson, G. Forrest, K. Mankes, T. F. Meiller, and R. A. Venezia. 2005. Prevalence of Candida dubliniensis fungemia at a large teaching hospital. Clin. Infect. Dis. 41:1064-1067. - PubMed
    1. NCCLS. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard M27-A. NCCLS, Wayne, Pa.
    1. Oliveira, K., G. Haase, C. Kurtzman, J. J. Hyldig-Nielsen, and H. Stender. 2001. Differentiation of Candida albicans and Candida dubliniensis by fluorescent in situ hybridization with peptide nucleic acid probes. J. Clin. Microbiol. 39:4138-4141. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources